248 related articles for article (PubMed ID: 15345133)
1. Engraftment of splenic tissue as a method to investigate repopulation by hematopoietic cells from host and donor marrow.
Shatry AM; Levy RB
Stem Cells Dev; 2004 Aug; 13(4):390-9. PubMed ID: 15345133
[TBL] [Abstract][Full Text] [Related]
2. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
Shatry AM; Jones M; Levy RB
Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
[TBL] [Abstract][Full Text] [Related]
3. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
[TBL] [Abstract][Full Text] [Related]
4. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
5. Long-term hemopoietic repopulation by Thy-1lo, Lin-, Ly6A/E+ cells.
Li CL; Johnson GR
Exp Hematol; 1992 Dec; 20(11):1309-15. PubMed ID: 1362957
[TBL] [Abstract][Full Text] [Related]
6. Investigation of murine spleen as a niche for hematopoiesis.
Tan JK; O'Neill HC
Transplantation; 2010 Jan; 89(2):140-5. PubMed ID: 20098275
[TBL] [Abstract][Full Text] [Related]
7. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation with T-cell-depleted grafts. II. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted bone marrow grafts disparate at minor histocompatibility antigens.
Leshem B; Tsuberi BZ; Lebendiker Z; Anafi-Ayalon M; Shalit M; Weiss L; Slavin S; Kedar E
Transplantation; 1987 Jun; 43(6):814-7. PubMed ID: 2954282
[TBL] [Abstract][Full Text] [Related]
9. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
Varas F; Bernard A; Bueren JA
Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799
[TBL] [Abstract][Full Text] [Related]
10. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
[TBL] [Abstract][Full Text] [Related]
11. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
12. Studies of allogeneic bone marrow and spleen cell transplantation in a murine model using ultraviolet-B light.
Pamphilon DH; Alnaqdy AA; Godwin V; Preece AW; Wallington TB
Blood; 1991 May; 77(9):2072-8. PubMed ID: 1826855
[TBL] [Abstract][Full Text] [Related]
13. Marrow engraftment of hematopoietic stem and progenitor cells is independent of Galphai-coupled chemokine receptors.
Wiesmann A; Spangrude GJ
Exp Hematol; 1999 May; 27(5):946-55. PubMed ID: 10340411
[TBL] [Abstract][Full Text] [Related]
14. SCID mouse as a model for transplantation studies.
Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
[TBL] [Abstract][Full Text] [Related]
15. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells.
El-Badri NS; Wang BY; Cherry ; Good RA
Exp Hematol; 1998 Feb; 26(2):110-6. PubMed ID: 9472800
[TBL] [Abstract][Full Text] [Related]
16. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
[TBL] [Abstract][Full Text] [Related]
17. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
18. Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD.
Cooper MH; Patrene KD; Vecchini F; Austin CA; Markus PM; Boggs SS
Bone Marrow Transplant; 1994 Sep; 14(3):355-62. PubMed ID: 7527689
[TBL] [Abstract][Full Text] [Related]
19. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
20. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
